(RYN) Rayonier - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7549071030

Stock: Timber, Land, Real Estate, REIT

Total Rating 45
Risk 99
Buy Signal -0.36
Risk 5d forecast
Volatility 23.7%
Relative Tail Risk -9.91%
Reward TTM
Sharpe Ratio -0.08
Alpha -11.10
Character TTM
Beta 0.486
Beta Downside 0.697
Drawdowns 3y
Max DD 29.28%
CAGR/Max DD -0.21

EPS (Earnings per Share)

EPS (Earnings per Share) of RYN over the last years for every Quarter: "2020-12": 0.08, "2021-03": 0.08, "2021-06": 0.22, "2021-09": 0.35, "2021-12": 0.01, "2022-03": 0.2, "2022-06": 0.16, "2022-09": 0.15, "2022-12": 0.11, "2023-03": 0.01, "2023-06": 0.05, "2023-09": 0.13, "2023-12": 0.17, "2024-03": 0.05, "2024-06": 0.02, "2024-09": 0.12, "2024-12": 0.27, "2025-03": -0.02, "2025-06": 0.06, "2025-09": 0.32,

Revenue

Revenue of RYN over the last years for every Quarter: 2020-12: 205.519, 2021-03: 191.447, 2021-06: 291.431, 2021-09: 364.726, 2021-12: 261.993, 2022-03: 222.041, 2022-06: 246.346, 2022-09: 195.287, 2022-12: 245.398, 2023-03: 179.082, 2023-06: 208.865, 2023-09: 201.579, 2023-12: 467.407, 2024-03: 113.704, 2024-06: 99.639, 2024-09: 194.993, 2024-12: 726.297, 2025-03: 82.922, 2025-06: 106.538, 2025-09: 177.531,

Description: RYN Rayonier January 12, 2026

Rayonier Inc. (NYSE:RYN) is a timberland REIT that, as of June 30 2025, owned or held long-term leases on roughly 2.0 million acres of productive softwood timberlands-about 1.74 million acres in the U.S. South and 307,000 acres in the Pacific Northwest.

Key recent metrics: FY 2024 saw adjusted EBITDA of $1.1 billion, supporting a dividend yield near 6.5%; the company’s timber price index rose ~4 % year-over-year, driven by strong housing starts and lumber demand. A primary sector driver is the long-term upward trend in construction activity, while climate-risk exposure (wildfire and disease) remains a material uncertainty that management mitigates through diversified geography and active forest management.

For a deeper dive into Rayonier’s valuation nuances and how they compare to peers, you might explore the analytics on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income: 775.6m TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.81 > 1.0
NWC/Revenue: 63.15% < 20% (prev 15.71%; Δ 47.43% < -1%)
CFO/TA 0.08 > 3% & CFO 292.7m > Net Income 775.6m
Net Debt (141.1m) to EBITDA (511.3m): 0.28 < 3
Current Ratio: 3.44 > 1.5 & < 3
Outstanding Shares: last quarter (156.4m) vs 12m ago 3.35% < -2%
Gross Margin: 42.85% > 18% (prev 0.30%; Δ 4255 % > 0.5%)
Asset Turnover: 31.37% > 50% (prev 25.17%; Δ 6.20% > 0%)
Interest Coverage Ratio: 15.36 > 6 (EBITDA TTM 511.3m / Interest Expense TTM 27.1m)

Altman Z'' 4.63

A: 0.20 (Total Current Assets 972.9m - Total Current Liabilities 282.6m) / Total Assets 3.49b
B: 0.15 (Retained Earnings 514.2m / Total Assets 3.49b)
C: 0.12 (EBIT TTM 415.8m / Avg Total Assets 3.49b)
D: 1.95 (Book Value of Equity 2.28b / Total Liabilities 1.17b)
Altman-Z'' Score: 4.63 = AA

Beneish M -3.66

DSRI: 0.33 (Receivables 20.1m/49.4m, Revenue 1.09b/875.7m)
GMI: 0.69 (GM 42.85% / 29.55%)
AQI: 0.80 (AQ_t 0.71 / AQ_t-1 0.89)
SGI: 1.25 (Revenue 1.09b / 875.7m)
TATA: 0.14 (NI 775.6m - CFO 292.7m) / TA 3.49b)
Beneish M-Score: -3.66 (Cap -4..+1) = AAA

What is the price of RYN shares?

As of February 13, 2026, the stock is trading at USD 22.49 with a total of 3,535,900 shares traded.
Over the past week, the price has changed by -0.13%, over one month by -3.02%, over three months by +2.89% and over the past year by -1.52%.

Is RYN a buy, sell or hold?

Rayonier has received a consensus analysts rating of 3.57. Therefor, it is recommend to hold RYN.
  • StrongBuy: 1
  • Buy: 2
  • Hold: 4
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the RYN price?

Issuer Target Up/Down from current
Wallstreet Target Price 26.7 18.6%
Analysts Target Price 26.7 18.6%
ValueRay Target Price 25.5 13.3%

RYN Fundamental Data Overview February 11, 2026

P/E Trailing = 8.6486
P/E Forward = 40.0
P/S = 5.2638
P/B = 2.9719
P/EG = 23.2357
Revenue TTM = 1.09b USD
EBIT TTM = 415.8m USD
EBITDA TTM = 511.3m USD
Long Term Debt = 845.1m USD (from longTermDebt, last quarter)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 1.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 141.1m USD (from netDebt column, last quarter)
Enterprise Value = 6.95b USD (6.81b + Debt 1.06b - CCE 919.6m)
Interest Coverage Ratio = 15.36 (Ebit TTM 415.8m / Interest Expense TTM 27.1m)
EV/FCF = 32.79x (Enterprise Value 6.95b / FCF TTM 211.9m)
FCF Yield = 3.05% (FCF TTM 211.9m / Enterprise Value 6.95b)
FCF Margin = 19.38% (FCF TTM 211.9m / Revenue TTM 1.09b)
Net Margin = 70.94% (Net Income TTM 775.6m / Revenue TTM 1.09b)
Gross Margin = 42.85% ((Revenue TTM 1.09b - Cost of Revenue TTM 624.8m) / Revenue TTM)
Gross Margin QoQ = 32.90% (prev 29.69%)
Tobins Q-Ratio = 1.99 (Enterprise Value 6.95b / Total Assets 3.49b)
Interest Expense / Debt = 0.64% (Interest Expense 6.77m / Debt 1.06b)
Taxrate = 1.14% (500.0k / 43.7m)
NOPAT = 411.0m (EBIT 415.8m * (1 - 1.14%))
Current Ratio = 3.44 (Total Current Assets 972.9m / Total Current Liabilities 282.6m)
Debt / Equity = 0.47 (Debt 1.06b / totalStockholderEquity, last quarter 2.28b)
Debt / EBITDA = 0.28 (Net Debt 141.1m / EBITDA 511.3m)
Debt / FCF = 0.67 (Net Debt 141.1m / FCF TTM 211.9m)
Total Stockholder Equity = 2.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.25% (Net Income 775.6m / Total Assets 3.49b)
RoE = 37.54% (Net Income TTM 775.6m / Total Stockholder Equity 2.07b)
RoCE = 14.28% (EBIT 415.8m / Capital Employed (Equity 2.07b + L.T.Debt 845.1m))
RoIC = 13.14% (NOPAT 411.0m / Invested Capital 3.13b)
WACC = 6.76% (E(6.81b)/V(7.87b) * Re(7.71%) + D(1.06b)/V(7.87b) * Rd(0.64%) * (1-Tc(0.01)))
Discount Rate = 7.71% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.70%
[DCF Debug] Terminal Value 76.26% ; FCFF base≈200.3m ; Y1≈131.5m ; Y5≈60.0m
Fair Price DCF = 4.54 (EV 1.51b - Net Debt 141.1m = Equity 1.37b / Shares 302.3m; r=6.76% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 14.73 | EPS CAGR: 152.0% | SUE: 1.51 | # QB: 1
Revenue Correlation: -30.90 | Revenue CAGR: -9.86% | SUE: 0.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.08 | Chg30d=-0.060 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.48 | Chg30d=-0.006 | Revisions Net=+0 | Growth EPS=+0.3% | Growth Revenue=-1.4%

Additional Sources for RYN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle